science

Vimseltinib

Vimseltinib is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Vimseltinib rather than just read about it. In short: Vimseltinib, sold under the brand name Romvimza, is an anti-cancer medication used for the treatment of tenosynovial giant cell tumor. Vimseltinib is a kinase inhibitor.

Key takeaways

Vimseltinib belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Vimseltinib to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Vimseltinib from memory before moving on to harder problems.

Reference excerpt

Vimseltinib, sold under the brand name Romvimza, is an anti-cancer medication used for the treatment of tenosynovial giant cell tumor. Vimseltinib is a kinase inhibitor. Vimseltinib is a macrophage colony-stimulating factor receptor antagonist. The most common adverse reactions, including laboratory abnormalities, include increased aspartate aminotransferase, periorbital edema, fatigue, rash, increased cholesterol, peripheral edema, face edema, decreased neutrophils, decreased leukocytes, pruritus, and increased alanine aminotransferase. Vimseltinib was approved for medical use in the United States in February 2025.

Medical uses Vimseltinib is indicated for the treatment of adults with symptomatic tenosynovial giant cell tumor for which surgical resection will potentially cause worsening functional limitation or severe morbidity.

History The efficacy of vimseltinib was evaluated in MOTION (NCT05059262), a double-blind, multicenter, randomized (2:1), placebo-controlled trial in participants with tenosynovial giant cell tumor for whom surgical resection may cause worsening functional limitation or severe morbidity. Eligible participants had a confirmed diagnosis of tenosynovial giant cell tumor with measurable disease (RECIST v1.1) with at least one lesion having a minimum size of 2 cm. Participants were randomized to placebo or vimseltinib, 30 mg twice weekly administered for 24 weeks, during the double-blind period (part 1). During the open-label period (part 2), patients could continue vimseltinib and those receiving placebos could crossover to vimseltinib. Randomization was stratified by tumor location (lower limb versus all other) and region (United States versus Non-US). A total of 123 participants were randomized: 83 to the vimseltinib arm and 40 to placebo during part 1. The US. Food and Drug Administration (FDA) granted the application for vimseltinib priority review designation.

Society and culture

Legal status Vimseltinib was approved for medical use in the United States in February 2025. In July 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Romvimza, intended for the treatment of adults with symptomatic tenosynovial giant cell tumor. The applicant for this medicinal product is Deciphera Pharmaceuticals (Netherlands) B.V. Vimseltinib was authorized for medical use in the European Union in September 2025.

Names Vimseltinib is the international nonproprietary name. Vimseltinib is sold under the brand name Romvimza.

References

External links Clinical trial number NCT05059262 for "Study of Vimseltinib for Tenosynovial Giant Cell Tumor (MOTION)" at ClinicalTrials.gov

Illustrations

Worked examples

Example 1 — a first encounter with Vimseltinib

Start with the simplest possible case. Write down what Vimseltinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Vimseltinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Vimseltinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Vimseltinib

In research: Vimseltinib appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Vimseltinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Vimseltinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antineoplastic drugs, Pyrazoles, Pyridines, so understanding it makes those chapters shorter.
In everyday life: Look for Vimseltinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Vimseltinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Vimseltinib in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Vimseltinib means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Vimseltinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Vimseltinib in simple terms?

Vimseltinib, sold under the brand name Romvimza, is an anti-cancer medication used for the treatment of tenosynovial giant cell tumor. Vimseltinib is a kinase inhibitor.

Why does Vimseltinib matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Vimseltinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Vimseltinib.